Not medical advice: Educational content only. Author is not a doctor. Consult a licensed healthcare professional.

Safety & Risk Questions

Critical safety information about repurposed compounds in oncology research

⚠️ Critical Warning

The compounds discussed on this website are NOT approved cancer treatments. Self-medication can be dangerous and potentially fatal. Always consult a licensed healthcare professional before considering any treatment.

Liver Toxicity Risks

Both fenbendazole and ivermectin are metabolized by the liver. Case reports document elevated liver enzymes (ALT, AST) and potential liver injury, particularly with fenbendazole.

Key Safety Points:

  • • Regular liver function monitoring is essential
  • • Using both compounds simultaneously may place additive stress on the liver
  • • Stop use immediately if experiencing symptoms of liver problems
  • • Symptoms include: yellowing skin/eyes, dark urine, severe fatigue, abdominal pain

Drug Interactions

Methylene Blue Warning

MUST NOT be taken with SSRIs, SNRIs, or MAO inhibitors due to severe serotonin syndrome risk. Also contraindicated in G6PD deficiency.

Combination Risks

DO NOT combine Ivermectin and Fenbendazole without medical supervision. Both are metabolized by the liver and combining them may increase hepatotoxicity risk.

Questions to Ask Your Doctor

  • 1.What are the potential interactions with my current medications?
  • 2.What monitoring would be required if I consider these compounds?
  • 3.Are there any contraindications based on my health history?
  • 4.What warning signs should I watch for?
  • 5.How might this affect my current cancer treatment plan?

When to Seek Emergency Care

Seek immediate medical attention if you experience:

  • • Severe abdominal pain
  • • Yellowing of skin or eyes
  • • Dark colored urine
  • • Persistent nausea/vomiting
  • • Extreme fatigue
  • • Confusion or disorientation
  • • Difficulty breathing
  • • Rapid heartbeat
Research LibraryFAQContact Us